Literature DB >> 27160032

Severe and refractory hypertension in a young woman.

René H Cuadra1, William B White2.   

Abstract

Refractory hypertension in a young person is an uncommon clinical problem, but one that may be referred to hypertension specialists. Factitious hypertension is fortunately quite rare but should be considered when evaluating patients who are refractory to numerous classes of antihypertensive therapies and have failed to achieve control despite input from multiple providers. A 19-year-old woman was referred to us after failing to achieve blood pressure control by a primary physician and two subspecialists in nephrology and hypertension; she also had numerous emergency department visits for symptomatic and severe hypertension. Exhaustive diagnostic testing for secondary causes and witnessed medication dosing in an outpatient setting was unrevealing. Subsequent inpatient admission demonstrated normalization of BPs with small doses of intravenous antihypertensive agents. During the hospitalization, she was observed "pocketing" her oral medications in the buccal folds and then discarding them in a trash container. Confrontation by psychiatrists and the hypertension specialists led to the admission that she had learned to start and stop beta-blockers and clonidine to induce severe, rebound hypertension. Factitious and induced hypertension is a rare cause of resistant or refractory hypertension. Nevertheless, hypertension specialists should suspect the diagnosis when there is a history of visits to multiple institutions and physicians, negative secondary workup, absence of overt target organ damage, history of psychiatric illness, and employment in the medical field.
Copyright © 2016 American Society of Hypertension. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Factitious hypertension; pseudoresistance; resistant hypertension

Mesh:

Substances:

Year:  2016        PMID: 27160032      PMCID: PMC4905787          DOI: 10.1016/j.jash.2016.03.193

Source DB:  PubMed          Journal:  J Am Soc Hypertens        ISSN: 1878-7436


  6 in total

1.  Case report: stimulation of severe hypertension as a means of malingering.

Authors:  B L Rude; R R Townsend; D J DiPette
Journal:  Am J Med Sci       Date:  1992-10       Impact factor: 2.378

2.  Factitious phaeochromocytoma: a case for Sherlock Holmes.

Authors:  I Portioli; R Valcavi
Journal:  Br Med J (Clin Res Ed)       Date:  1981 Dec 19-26

3.  Munchausen syndrome: a novel cause of drug-resistant hypertension.

Authors:  Achille C Pessina; Valeria Bisogni; Ambrogio Fassina; Gian Paolo Rossi
Journal:  J Hypertens       Date:  2013-07       Impact factor: 4.844

4.  Simulation of a pheochromocytoma--Munchausen syndrome.

Authors:  D Spitzer; D Bongartz; T H Ittel; H G Sieberth
Journal:  Eur J Med Res       Date:  1998-12-16       Impact factor: 2.175

5.  Refractory hypertension: definition, prevalence, and patient characteristics.

Authors:  Maria Czarina Acelajado; Roberto Pisoni; Tanja Dudenbostel; Louis J Dell'Italia; Falynn Cartmill; Bin Zhang; Stacey S Cofield; Suzanne Oparil; David A Calhoun
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-11-15       Impact factor: 3.738

6.  Rationale for establishing a mechanism to increase reimbursement to hypertension specialists.

Authors:  William J Elliott; Brent Egan; Thomas D Giles; George L Bakris; William B White; Torry M Sansone
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-04-11       Impact factor: 3.738

  6 in total
  1 in total

1.  Therapeutic drug monitoring-guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence.

Authors:  Valeria Avataneo; Amedeo De Nicolò; Franco Rabbia; Elisa Perlo; Jacopo Burrello; Elena Berra; Marco Pappaccogli; Jessica Cusato; Antonio D'Avolio; Giovanni Di Perri; Franco Veglio
Journal:  Br J Clin Pharmacol       Date:  2018-08-15       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.